427 related articles for article (PubMed ID: 23688595)
21. Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Al Shawabkeh MA; Al Sulaiti M; Al Sa'ey H; Ganesan S
Am J Case Rep; 2016 Dec; 17():934-938. PubMed ID: 27932776
[TBL] [Abstract][Full Text] [Related]
22. Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India.
Bugalia A; Manipadam MT; Nair S
Leuk Lymphoma; 2013 Jun; 54(6):1201-7. PubMed ID: 23098105
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
24. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A
J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508
[TBL] [Abstract][Full Text] [Related]
25. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
Zhang S; Li T; Zhang B; Nong L; Aozasa K
Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
[TBL] [Abstract][Full Text] [Related]
26. Current management of nasal NK/T-cell lymphoma.
Au WY
Oncology (Williston Park); 2010 Apr; 24(4):352-8. PubMed ID: 20464847
[TBL] [Abstract][Full Text] [Related]
27. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
29. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
[TBL] [Abstract][Full Text] [Related]
30. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
31. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
[TBL] [Abstract][Full Text] [Related]
32. An unusual presentation of NK/T-cell lymphoma, nasal-type in the United States.
Kidwai SM; Parasher AK; Lin FY
Am J Otolaryngol; 2015; 36(1):80-3. PubMed ID: 25304998
[TBL] [Abstract][Full Text] [Related]
33. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
34. Primary spinal natural killer/T-cell lymphoma successfully treated with concurrent chemoradiotherapy and autologous stem cell transplantation.
Kim KT; Kim YB; Kim HJ; Cha YJ; Lee SJ; Park E
Spine (Phila Pa 1976); 2012 May; 37(10):E629-32. PubMed ID: 22089400
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
[TBL] [Abstract][Full Text] [Related]
36. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
37. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
[TBL] [Abstract][Full Text] [Related]
38. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
39. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.
Cuadra-Garcia I; Proulx GM; Wu CL; Wang CC; Pilch BZ; Harris NL; Ferry JA
Am J Surg Pathol; 1999 Nov; 23(11):1356-69. PubMed ID: 10555004
[TBL] [Abstract][Full Text] [Related]
40. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]